Download Files:
Products Details
Product Description
– RIPK1-IN-15 (Compound 2.5) is a potent inhibitor of RIPK1. RIPK1-IN-15 has the potential for the research neurodegenerative, autoimmune, and inflammatory diseases[1].
Web ID
– HY-143480
Shipping
– Room temperature
Applications
– COVID-19-immunoregulation
Molecular Formula
– C19H19N3O2
References
– [1]Sabnis RW. Novel RIPK1 Inhibitors for Treating Neurodegenerative, Autoimmune, and Inflammatory Diseases. ACS Med Chem Lett. 2022 Mar 2;13(4):524-525.
CAS Number
– 2755704-34-6
Molecular Weight
– 321.37
SMILES
– O=C(N1N=CC[C@H]1C2=CC=CC=C2)N3CC(OC4=CC=CC=C4)C3
Clinical Information
– No Development Reported
Research Area
– Inflammation/Immunology; Neurological Disease
Solubility
– 10 mM in DMSO
Target
– RIP kinase
Isoform
– RIPK1
Pathway
– Apoptosis
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
